Cargando…

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients

Tyrosinemia type 1 (TT1) treatment with 2-(2-nitro-4-trifluormethyl-benzyl)-1,3-cyclohexanedione (NTBC) and a phenylalanine-tyrosine restricted diet is associated with low phenylalanine concentrations. Phenylalanine supplementation is prescribed without comprehensive consideration about its effect o...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Ginkel, Willem G., van Reemst, Hannah E., Kienstra, Nienke S., Daly, Anne, Rodenburg, Iris L., MacDonald, Anita, Burgerhof, Johannes G.M., de Blaauw, Pim, van de Krogt, Jennifer, Santra, Saikat, Heiner-Fokkema, M. Rebecca, van Spronsen, Francjan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893509/ https://www.ncbi.nlm.nih.gov/pubmed/31752110 http://dx.doi.org/10.3390/nu11112816

Ejemplares similares

Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1
por: van Ginkel, Willem G., et al.
Publicado: (2017)

Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day
por: Kienstra, Nienke S., et al.
Publicado: (2017)

Dried blood spot versus venous blood sampling for phenylalanine and tyrosine
por: van Vliet, Kimber, et al.
Publicado: (2020)

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
por: van Ginkel, Willem G., et al.
Publicado: (2019)

The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult Pah-Enu2 Mice
por: van Vliet, Danique, et al.
Publicado: (2019)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial
por: Daly, Anne, et al.
Publicado: (2019)

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria
por: Hughes, Juliette H., et al.
Publicado: (2020)

Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah(enu2) Mice
por: van der Goot, Els, et al.
Publicado: (2022)

Exploring the therapeutic potential of modern and ancestral phenylalanine/tyrosine ammonia-lyases as supplementary treatment of hereditary tyrosinemia
por: Hendrikse, Natalie M., et al.
Publicado: (2020)

Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
por: Daly, A., et al.
Publicado: (2019)

Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
por: van Ginkel, Willem G., et al.
Publicado: (2016)

Monitoring phenylalanine concentrations in the follow‐up of phenylketonuria patients: An inventory of pre‐analytical and analytical variation
por: Coene, Karlien L. M., et al.
Publicado: (2020)

Aspartame and Phe-Containing Degradation Products in Soft Drinks across Europe
por: van Vliet, Kimber, et al.
Publicado: (2020)

Phenylalanine Binding Is Linked to Dimerization of the Regulatory Domain of Phenylalanine Hydroxylase
por: Zhang, Shengnan, et al.
Publicado: (2014)

Activation of Phenylalanine Hydroxylase by Phenylalanine Does Not Require Binding in the Active Site
por: Roberts, Kenneth M., et al.
Publicado: (2014)

Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Preventive use of nitisinone in alkaptonuria
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2021)

(13)C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients
por: Teraishi, T, et al.
Publicado: (2012)

Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria
por: Singh, Virender, et al.
Publicado: (2014)

Protein Type, Protein Dose, and Age Modulate Dietary Protein Digestion and Phenylalanine Absorption Kinetics and Plasma Phenylalanine Availability in Humans
por: Gorissen, Stefan H M, et al.
Publicado: (2020)

A Methylidene Group in the Phosphonic Acid Analogue of Phenylalanine Reverses the Enantiopreference of Binding to Phenylalanine Ammonia‐Lyases
por: Bata, Zsófia, et al.
Publicado: (2017)

Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine
por: Kun, Szilárd, et al.
Publicado: (2015)

Engineered Escherichia coli platforms for tyrosine-derivative production from phenylalanine using phenylalanine hydroxylase and tetrahydrobiopterin-regeneration system
por: Satoh, Yasuharu, et al.
Publicado: (2023)

Recommendations for the nutrition management of phenylalanine hydroxylase deficiency
por: Singh, Rani H., et al.
Publicado: (2014)

Biosynthesis and Metabolic Fate of Phenylalanine in Conifers
por: Pascual, María B., et al.
Publicado: (2016)

Synthesis of d- and l-Phenylalanine Derivatives by Phenylalanine Ammonia Lyases: A Multienzymatic Cascade Process**
por: Parmeggiani, Fabio, et al.
Publicado: (2015)

Identification of a plastidial phenylalanine exporter that influences flux distribution through the phenylalanine biosynthetic network
por: Widhalm, Joshua R., et al.
Publicado: (2015)

Synthesis of d‐ and l‐Phenylalanine Derivatives by Phenylalanine Ammonia Lyases: A Multienzymatic Cascade Process
por: Parmeggiani, Fabio, et al.
Publicado: (2015)

The production of l- and d-phenylalanines using engineered phenylalanine ammonia lyases from Petroselinum crispum
por: Tork, Souad Diana, et al.
Publicado: (2019)

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
por: Pataskar, Abhijeet, et al.
Publicado: (2022)

Phenylalanine free infant formula in the dietary management of phenylketonuria
por: Yilmaz, Ozlem, et al.
Publicado: (2023)

Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pinto, Alex, et al.
Publicado: (2023)

Adaptation of Phenylalanine and Tyrosine Catabolic Pathway to Hibernation in Bats
por: Pan, Yi-Hsuan, et al.
Publicado: (2013)

Phenylalanine and Tyrosine Kinetics in Critically Ill Children with Sepsis
por: Castillo, Leticia, et al.
Publicado: (1994)

Identification of the Tyrosine- and Phenylalanine-Derived Soluble Metabolomes of Sorghum
por: Simpson, Jeffrey P., et al.
Publicado: (2021)

Phenylalanine metabolism and tetrahydrobiopterin bio-availability in COVID-19 and HIV
por: Mason, Shayne, et al.
Publicado: (2023)

A switchable self-assembling and disassembling chiral system based on a porphyrin-substituted phenylalanine–phenylalanine motif
por: Charalambidis, Georgios, et al.
Publicado: (2016)

Blood phenylalanine fluctuation in phenylketonuric children treated by BH4 or low-phenylalanine diet from birth
por: Theron, Maurane, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i6r0ddi46t1r501kbu0gmr81ii